Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001659022 | SCV001875173 | uncertain significance | not provided | 2021-02-17 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23300259, 23431742, 22090377) |
Fulgent Genetics, |
RCV002477878 | SCV002791387 | uncertain significance | Polycystic kidney disease, adult type | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004741051 | SCV005346384 | uncertain significance | PKD1-related disorder | 2024-08-13 | no assertion criteria provided | clinical testing | The PKD1 c.2896C>T variant is predicted to result in the amino acid substitution p.Arg966Trp. This variant has been reported in individuals with autosomal dominant polycystic kidney disease (ADPKD) (Laleye et al. 2012. PubMed ID: 23431742; Neumann et al. 2013. PubMed ID: 23300259). Of note, a different substitution at the same amino acid position (p.Arg966Pro) was reported to segregate with ADPKD in one Chinese family (He et al. 2018. PubMed ID: 30333007) and occurred de novo in a presumably unrelated patient (Xu et al. 2018. PubMed ID: 29529603). The c.2896C>T (p.Arg966Trp) variant is reported in 0.036% of alleles in individuals of African descent in gnomAD, which is more common than being expected for a pathogenic variant. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |